Strengthening Benefit-Cost Analyses of Substance Abuse Prevention

加强预防药物滥用的效益成本分析

基本信息

批准号：
8720742
负责人：
Daniel Max Crowley
金额：
$ 5.33万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-09-01 至 2015-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8720742
关键词：
5 year old Accounting Adopted Adoption Adult Area Child Childhood Communities Cost Analysis Cost of Illness Cost-Benefit Analysis Costs and Benefits Data Economics Ethics Evaluation Foundations Funding Future Health Services Incidence Income Intervention Link Literature Logistics Longitudinal Studies Marketing Modeling National Institute of Drug Abuse Outcome Participant Policies Prevention Prevention program Preventive Intervention Price Process Program Development Public Health Randomized Research Research Personnel Research Priority Resources Review Literature Risk Risk Factors Sampling Science Services Shadowing (Histology)Social Values Substance abuse problem Support System System Time Work base boys cost design evidence base follow-up girls high risk human capital improved insight kindergarten prevent programs public health relevance reduced substance abuse social substance abuse prevention uptake

项目摘要

DESCRIPTION (provided by applicant): Substance abuse is estimated to cost the nation over $180 billion annually (French et al., 2008; Harwood, 2004; Mark et al., 2007; Schori, 2011), yet little is known about whether current evidence-based preventive interventions (EBPI) can efficiently reduce these costs (i.e., whether program benefits are greater than the cost of operating the program; Aos et al., 2004, 2011; Heckman et al., 2010). This is largely because researchers lack three components vital to conducting high-quality benefit-costs analyses (BCAs) that reliably estimate the efficiency of substance abuse (SA) prevention efforts (Bukoski et al., 1998; Crowley et al., 2011e; Karoly, 2011; O'Connell et al., 2009). These include a lack of (1) cost estimates that account for the resources needed to adopt, implement and sustain SA prevention programs, (2) estimates of the social benefits gained from reducing SA risk factors in monetary terms, and (3) guidance around best practices and research priorities for evaluating SA prevention costs and benefits. To strengthen BCA practice, the research strategy described in this proposal will estimate and model the systemic costs of a large-scale NIDA-funded SA prevention effort, estimate the societal value of targeting specific SA risk factors, and identify best practices and research priorities for BCAs of SA prevention. Further, this work will provide the foundation for a productive research program as I transition to an independent investigator.

描述（由申请人提供）：估计滥用药物每年使全国损失超过1800亿美元（French et al。，2008; Harwood，2004; Mark等，2007; Schori，2007; Schori，2011年），但对于当前基于证据的预防性干预措施（EBPI）是否有效降低这些成本是否有效地降低了这些程序的成本，但该计划是否更大。 2010）。这主要是因为研究人员缺乏对进行高质量福利-COSTS分析（BCA）至关重要的三个组成部分，这些分析可靠地估计了滥用药物的效率（SA）预防工作（Bukoski et al。，1998; Crowley等，2011e; 2011e; Karoly，Karoly，2011; O'Conconnell等，2009）。这些包括缺乏（1）成本估计，说明采用，实施和维持预防SA预防计划所需的资源，（2）估计从减少SA风险因素的社会收益中，以货币术语减少SA风险因素，以及（3）围绕评估SA预防成本和收益的最佳实践和研究优先级的指导。为了加强BCA实践，本提案中描述的研究策略将估算并模拟大规模NIDA资助的SA预防工作的系统成本，估算靶向特定SA风险因素的社会价值，并确定预防BCA的最佳实践和研究优先级。此外，这项工作将在我过渡到独立研究者时为生产研究计划奠定基础。